Common drug could stop dangerous bleeding in blood cancer patients
NCT ID NCT06599762
Summary
This study is testing if a widely available, inexpensive drug called tranexamic acid can safely reduce bleeding episodes in outpatients with serious blood cancers (MDS or AML). About 75 adult patients with low platelet counts will be randomly assigned to receive either the drug or a placebo pill. Researchers will monitor both groups to see if the medication lowers the risk or severity of bleeding, which is a major quality-of-life and safety concern for these patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROMES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CancerCare Manitoba
RECRUITINGWinnipeg, Manitoba, R3E 0V9, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.